NCT05375643 - SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

December 30, 2027

Study Completion Date

July 30, 2028

Conditions

Gastrointestinal CancerHematologic CancerThoracic Cancer

Interventions

BEHAVIORAL

SURGE

Video with or without person to person guidance to support decision making around genetic testing

Trial Locations (3)

RECRUITING

Dana Farber Cancer Institute, Boston

RECRUITING

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Brighton

NOT_YET_RECRUITING

Dana-Farber Cancer Instiute - Merrimack Valley, Methuen